Karen Zaderej Insider Profile

4 Followers
Karen Zaderej, CEO, Director at AxoGen, holds 16.50K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 1.14M shares in AxoGen (Ticker: AXGN), holds 62.35K shares in Viveve Medical (Ticker: VIVE). Most recently, Karen Zaderej Bought ― shares of EyePoint Pharmaceuticals on Aug 21, 2024 for an estimated value of 99.75K.
tipranks
Karen Zaderej

Karen Zaderej
AxoGen (AXGN)
CEO, Director

Ranked #4,316 out of 99,218 Corporate Insiders

Profitable Transactions

89%
8 out of 9 Profitable Transactions

Average Return

+36.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$17M
98.88%
1.11%
0.01%
A breakdown of Karen Zaderej's holdings

Insider Roles

AxoGen
(AXGN)
CEO, Director
EyePoint Pharmaceuticals
(EYPT)
Director
Viveve Medical
(VIVE)
Director
Roles that Karen Zaderej holds in companies

Most Profitable Insider Trade

Stock:
AxoGen
(AXGN)
Rating:Informative Buy
Date:Oct 14, 2016 - Oct 14, 2017
Return:+122.40%
The most profitable trade made by Karen Zaderej

Karen Zaderej's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AxoGen
Mar 25, 2024
CEO, Director
Uninformative Buy
545.60K
$17.11M
Viveve Medical
Jul 02, 2019
Director
Uninformative Buy
$1.87K
EyePoint Pharmaceuticals
Aug 21, 2024
Director
Informative Buy
99.75K
$191.56K
List of latest transactions for each holding click on a transaction to see Karen Zaderej's performance on stock

Karen Zaderej insider profile FAQ

What is the percentage of profitable transactions made by Karen Zaderej?
The percentage of profitable transactions made by Karen Zaderej is 89%.
    What is the average return per transaction made by Karen Zaderej?
    The average return per transaction made by Karen Zaderej is 36.30%.
      What stocks does Karen Zaderej hold?
      Karen Zaderej holds: AXGN, VIVE, EYPT stocks.
        What was Karen Zaderej’s latest transaction?
        Karen Zaderej latest transaction was an Informative Buy of $99.75K.
          What was Karen Zaderej's most profitable transaction?
          Karen Zaderej’s most profitable transaction was an Informative Buy of AXGN stock on October 14, 2016. The return on the trade was 122.40%.
            What is Karen Zaderej's role in AxoGen?
            Karen Zaderej's role in AxoGen is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.